Bottle of Lies: The Inside Story of the Generic Drug Boom Audiobook (Free)

From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug increase that reveals the life-threatening dangers posed by globalization-The Jungle for pharmaceuticals

The widespread use of generic medicines has been hailed as one of the most important public health developments of the twentieth century. Today, almost 90 percent of our pharmaceutical marketplace is made up of generics, the majority of which are produced overseas. We’ve been reassured about Container of Lies: The Inside Story from the Generic Drug Growth by our pharmacists, our doctors, and our regulators that the generic and brand-name drugs are identical, generics simply cheaper. But is usually this really accurate?

Katherine Eban’s Bottle of Lays exposes the common deceit behind generic medication manufacturing-creating terrifying dangers for global health. Drawing on special accounts from whistleblowers, inspectors, and regulators, as well as thousands of web pages of confidential inner FDA paperwork, Eban reveals an industry where fraud is certainly rampant, businesses falsify data, and professionals circumvent almost every basic principle of safe manufacturing to minimize price and maximize revenue. Meanwhile, sufferers unwittingly consume adulterated medicine with unpredictable as well as life-threatening effects.

The storyplot of generic drugs is truly global: it connects middle America to sub-Saharan Africa, China, India, and Brazil, and encompasses every marketplace banking over the promise of a low-cost cure. Considering that tens of an incredible number of sufferers take drugs of dubious quality accepted with fake data, the generics market is the best litmus test of globalization: what’s the chance of moving drug manufacturing offshore, and is it worth the cost savings?

A study with international sweep, exotic configurations, molecular mayhem, and a lot of money at its core, Bottle of Lays reveals the way the world’s ideal public-health innovation is becoming one of its most astonishing swindles.